Analogs of a Natural Peptaibol Exert Anticancer Activity in Both Cisplatin- and Doxorubicin-Resistant Cells and in Multicellular Tumor Spheroids
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Analogs of a Natural Peptaibol Exert Anticancer Activity in Both Cisplatin- and Doxorubicin-Resistant Cells and in Multicellular Tumor Spheroids
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 16, Pages 8362
Publisher
MDPI AG
Online
2021-08-04
DOI
10.3390/ijms22168362
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hodgkin Lymphoma: 2020 update on diagnosis, risk‐stratification, and management
- (2020) Stephen M. Ansell AMERICAN JOURNAL OF HEMATOLOGY
- The untapped potential of ascites in ovarian cancer research and treatment
- (2020) Caroline Elizabeth Ford et al. BRITISH JOURNAL OF CANCER
- Adipose-Derived Stem Cells Primed with Paclitaxel Inhibit Ovarian Cancer Spheroid Growth and Overcome Paclitaxel Resistance
- (2020) Cinzia Borghese et al. Pharmaceutics
- Re-engineering Antimicrobial Peptides into Oncolytics Targeting Drug-Resistant Ovarian Cancers
- (2020) Matthew R. Aronson et al. Cellular and Molecular Bioengineering
- Lipid composition of the cancer cell membrane
- (2020) Wojciech Szlasa et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Antimicrobial Peptides as Anticancer Agents: Functional Properties and Biological Activities
- (2020) Anna Lucia Tornesello et al. MOLECULES
- Anti-cancer peptides: classification, mechanism of action, reconstruction and modification
- (2020) Mingfeng Xie et al. Open Biology
- Antimicrobial Peptide Reverses ABCB1-Mediated Chemotherapeutic Drug Resistance
- (2020) Xiaofang Luo et al. Frontiers in Pharmacology
- Hodgkin lymphoma
- (2020) Joseph M. Connors et al. Nature Reviews Disease Primers
- Targeted Amino Acid Substitutions in a Trichoderma Peptaibol Confer Activity against Fungal Plant Pathogens and Protect Host Tissues from Botrytis cinerea Infection
- (2020) Marta De Zotti et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- New Insights into Therapy-Induced Progression of Cancer
- (2020) Polina V. Shnaider et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Exploring the Potential of Drug Response Assays for Precision Medicine in Ovarian Cancer
- (2020) Tanya Singh et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Platinum Resistance in Ovarian Cancer: Role of DNA Repair
- (2019) Giovanna Damia et al. Cancers
- Trichogin GA IV alignment and oligomerization in phospholipid bilayers
- (2019) Evgeniy S. Salnikov et al. CHEMBIOCHEM
- Tumor Targeting by Peptide-Decorated Gold Nanoparticles
- (2019) Barbara Albertini et al. MOLECULAR PHARMACEUTICS
- A gold mine for drug discovery: Strategies to develop cyclic peptides into therapies
- (2019) Xiaoshu Jing et al. MEDICINAL RESEARCH REVIEWS
- Stapled Peptides—A Useful Improvement for Peptide-Based Drugs
- (2019) Mattia Moiola et al. MOLECULES
- A view on drug resistance in cancer
- (2019) Neil Vasan et al. NATURE
- Precision medicine by designer interference peptides: applications in oncology and molecular therapeutics
- (2019) Anabel Sorolla et al. ONCOGENE
- Inhibition of MDR1 Overcomes Resistance to Brentuximab Vedotin in Hodgkin Lymphoma
- (2019) Robert Chen et al. CLINICAL CANCER RESEARCH
- Therapeutic peptides: Historical perspectives, current development trends, and future directions
- (2018) Jolene L. Lau et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Role of tumor microenvironment in the pathobiology of ovarian cancer: Insights and therapeutic opportunities
- (2018) Alia Ghoneum et al. Cancer Medicine
- 3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs
- (2018) Ana S. Nunes et al. BIOTECHNOLOGY AND BIOENGINEERING
- Emerging Therapeutics to Overcome Chemoresistance in Epithelial Ovarian Cancer: A Mini-Review
- (2017) Robert Cornelison et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Drug delivery to solid tumors: the predictive value of the multicellular tumor spheroid model for nanomedicine screening
- (2017) Marie Millard et al. International Journal of Nanomedicine
- The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach
- (2016) Annalisa Dalzini et al. Scientific Reports
- Preclinical activity of the repurposed drug auranofin in classical Hodgkin lymphoma
- (2015) M. Celegato et al. BLOOD
- Diagnostic Exome Sequencing Identifies a Novel Gene,EMILIN1, Associated with Autosomal-Dominant Hereditary Connective Tissue Disease
- (2015) Alessandra Capuano et al. HUMAN MUTATION
- Preclinical Activity of the Liposomal Cisplatin Lipoplatin in Ovarian Cancer
- (2014) N. Casagrande et al. CLINICAL CANCER RESEARCH
- A three-dimensional microenvironment alters protein expression and chemosensitivity of epithelial ovarian cancer cells in vitro
- (2013) Janet Myungjin Lee et al. LABORATORY INVESTIGATION
- Latest research and treatment of advanced-stage epithelial ovarian cancer
- (2013) Robert L. Coleman et al. Nature Reviews Clinical Oncology
- Detection of ABCC1 expression in classical Hodgkin lymphoma is associated with increased risk of treatment failure using standard chemotherapy protocols
- (2012) Wesley Greaves et al. Journal of Hematology & Oncology
- Membrane-active host defense peptides – Challenges and perspectives for the development of novel anticancer drugs
- (2011) Sabrina Riedl et al. CHEMISTRY AND PHYSICS OF LIPIDS
- Trichogin GA IV: A versatile template for the synthesis of novel peptaibiotics
- (2011) Marta De Zotti et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Multicellular spheroids in ovarian cancer metastases: Biology and pathology
- (2009) Kristy Shield et al. GYNECOLOGIC ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now